Vaccine and Infectious Disease Division

Scientist with petri dish

Featured News from VIDD

Betz Halloran

Fred Hutchinson Cancer Research Center named a MIDAS Center of Excellence

Researchers at Fred Hutchinson Cancer Research Center, including several VIDD faculty, received a five-year, $12.5 million award from the National Institute of General Medical Sciences that designates the Seattle campus as a MIDAS Center of Excellence. Models of Infectious Disease Agency Study (MIDAS) centers are designated to play a role in planning for national emergencies such as a pandemic or an act of bioterrorism. Read more »

More Featured News from VIDD »

Upcoming VIDD Events

 

FHCRC Shared Resources
Tuesday, October 7

Faculty Meeting
Faculty Meeting
Tuesday, December 16

VIDD Faculty Stories

 

Curing chronic viral infections with Keith Jerome
It wasn’t very long ago that the idea of an HIV cure was scoffed at. The concept of a curative method for dealing with chronic viral infections, as opposed to preventative (such as vaccines) or treatment (such as antivirals), has a history of controversy among the field.

More VIDD Faculty Stories »

VIDD Publication Spotlight

 

A model for single cell gene expression variability
Cell growth is a dynamic, stochastic process. In any one homogenous cell population the individual cells are not actually all in the same phase of the cell cycle.

More VIDD News »

Find VIDD Faculty

 

International Spotlight

 

Uganda
Uganda offers a unique setting to study the impact of infections on the development and clinical course of several cancers.

More International Programs »

VIDD Announcements

 

VIDD’s Population Sciences (PS) Program has changed its name to Biostatistics, Bioinformatics, and Epidemiology (BBE). 


Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.